|
CLDI Calidi Biotherapeutics Inc 1855485 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-4,108,000.00 |
| Balance Sheet |
|
Current Assets
|
$7,353,000.00 |
|
Assets
|
$9,591,000.00 |
|
Current Liabilities
|
$3,836,000.00 |
|
Liabilities
|
$4,656,000.00 |
|
Equity
|
$4,935,000.00 |
|
Shares Out
|
11786725.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,116,000.00 |
|
Investing Cash Flow
|
$-5,000.00 |
| Market Analysis |
Market Cap
|
$1,060,805.25 |
|
Price
|
$1.58 |
|
BVPS
|
0.42 |
|
PB
|
0.21 |
|
EPS
|
-0.43 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLDI documents filed with the SEC.
CLDI Filings
Clear
